Japan
Regenerative medicine product development using stem cells
Manufacturing and sales of regenerative medicine products
Research and development of stem cell therapies
Licensing and commercialization of inducible inhibitory T-cells (JB-101)
会社名
Group
親会社
子会社
得意先
仕入先
業務提携
銀行等
株主等
2026-08-09 10:41 (Model: ggml-org/gpt-oss-20b )
